Early Access — free while we kick the tires
EdgarHawk

Chen Bihua

1 filing analyzed · 1 company · Latest 2025-10-01

Companies

Company Buys Sells Direction
MoonLake Immunotherapeutics MLTX 0 5 Net selling

Activity

October 2025
high
Sell
6,499,978 shares
$46,868,184
Significance 8/10

Insider Chen Bihua sells 6,499,978 shares for $46,868,184 as MLTX stock has declined 88.6% from 52-week high

Chen Bihua executed 5 separate sales totaling 6,499,978 shares for $46,868,184.10 on 2025-09-29 and 2025-09-30, reducing holdings by 76.5% to 1,994,173 shares post-transaction. The sales occurred at prices ranging from $6.61 to $9.38, with a blended average of $7.21, while the current price stands at $7.06. The stock has collapsed 88.6% from its 52-week high of $61.99 and declined 87.3% over the prior 30 days. MoonLake is unprofitable, reporting a net loss of $55,220,000 for the most recent fiscal year. The insider's same-ticker history shows a 90-day timing pattern of 4 of 5 prior buys yielding positive 90-day returns, suggesting prior purchase discipline at this ticker; however, this massive liquidation occurs in a severely depressed price environment, well below prior transaction prices and following an extended decline over the filing period.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access